Extensive impact of non-antibiotic drugs on human gut bacteria
Lisa Maier, Mihaela Pruteanu, Michael Kuhn, Georg Zeller, Anja Telzerow, Exene Erin Anderson, Ana Rita Brochado, Keith Conrad Fernandez, Hitomi Dose, Hirotada Mori, Kiran Raosaheb Patil, Peer Bork, Athanasios Typas, Lisa Maier, Mihaela Pruteanu, Michael Kuhn, Georg Zeller, Anja Telzerow, Exene Erin Anderson, Ana Rita Brochado, Keith Conrad Fernandez, Hitomi Dose, Hirotada Mori, Kiran Raosaheb Patil, Peer Bork, Athanasios Typas
Abstract
A few commonly used non-antibiotic drugs have recently been associated with changes in gut microbiome composition, but the extent of this phenomenon is unknown. Here, we screened more than 1,000 marketed drugs against 40 representative gut bacterial strains, and found that 24% of the drugs with human targets, including members of all therapeutic classes, inhibited the growth of at least one strain in vitro. Particular classes, such as the chemically diverse antipsychotics, were overrepresented in this group. The effects of human-targeted drugs on gut bacteria are reflected on their antibiotic-like side effects in humans and are concordant with existing human cohort studies. Susceptibility to antibiotics and human-targeted drugs correlates across bacterial species, suggesting common resistance mechanisms, which we verified for some drugs. The potential risk of non-antibiotics promoting antibiotic resistance warrants further exploration. Our results provide a resource for future research on drug-microbiome interactions, opening new paths for side effect control and drug repurposing, and broadening our view of antibiotic resistance.
Conflict of interest statement
Author Information
The authors declare no competing financial interests.
Figures
References
- Kåhrström CT, Pariente N, Weiss U. Intestinal microbiota in health and disease. Nature. 2016;535:47. doi: 10.1038/535047a.
- Forslund K, et al. Disentangling type 2 diabetes and metformin treatment signatures in the human gut microbiota. Nature. 2015;528:262–266. doi: 10.1038/nature15766.
- Imhann F, et al. Proton pump inhibitors affect the gut microbiome. Gut. 2016;65:740–748. doi: 10.1136/gutjnl-2015-310376.
- Jackson MA, et al. Proton pump inhibitors alter the composition of the gut microbiota. Gut. 2016;65:749–756. doi: 10.1136/gutjnl-2015-310861.
- Rogers MA, Aronoff DM. The influence of non-steroidal anti-inflammatory drugs on the gut microbiome. Clin Microbiol Infect. 2016;22:178 e171–179. doi: 10.1016/j.cmi.2015.10.003.
- Flowers SA, Evans SJ, Ward KM, McInnis MG, Ellingrod VL. Interaction between Atypical Antipsychotics and the Gut Microbiome in a Bipolar Disease Cohort. Pharmacotherapy. 2016 doi: 10.1002/phar.1890.
- Falony G, et al. Population-level analysis of gut microbiome variation. Science. 2016;352:560–564. doi: 10.1126/science.aad3503.
- Tramontano M, et al. Nutritional preferences of the human gut bacteria reveal their metabolic idiosyncasies. Nat Microbiol. 2017 accepted.
- Ejim L, et al. Combinations of antibiotics and nonantibiotic drugs enhance antimicrobial efficacy. Nat Chem Biol. 2011;7:348–350. doi: 10.1038/nchembio.559.
- Taber HW, Mueller JP, Miller PF, Arrow AS. Bacterial uptake of aminoglycoside antibiotics. Microbiol Rev. 1987;51:439–457.
- Blaser MJ. Antibiotic use and its consequences for the normal microbiome. Science. 2016;352:544–545. doi: 10.1126/science.aad9358.
- Rani N, Sharma A, Singh R. Imidazoles as promising scaffolds for antibacterial activity: a review. Mini Rev Med Chem. 2013;13:1812–1835.
- Harbut MB, et al. Auranofin exerts broad-spectrum bactericidal activities by targeting thiol-redox homeostasis. Proc Natl Acad Sci U S A. 2015;112:4453–4458. doi: 10.1073/pnas.1504022112.
- Farha MA, et al. Antagonism screen for inhibitors of bacterial cell wall biogenesis uncovers an inhibitor of undecaprenyl diphosphate synthase. Proc Natl Acad Sci U S A. 2015;112:11048–11053. doi: 10.1073/pnas.1511751112.
- Pasolli E, Truong DT, Malik F, Waldron L, Segata N. Machine Learning Meta-analysis of Large Metagenomic Datasets: Tools and Biological Insights. PLoS Comput Biol. 2016;12:e1004977. doi: 10.1371/journal.pcbi.1004977.
- Koh A, De Vadder F, Kovatcheva-Datchary P, Bäckhed F. From Dietary Fiber to Host Physiology: Short-Chain Fatty Acids as Key Bacterial Metabolites. Cell. 2016;165:1332–1345. doi: 10.1016/j.cell.2016.05.041.
- Arumugam M, et al. Enterotypes of the human gut microbiome. Nature. 2011;473:174–180. doi: 10.1038/nature09944. nature09944 [pii]
- Donaldson GP, Lee SM, Mazmanian SK. Gut biogeography of the bacterial microbiota. Nat Rev Microbiol. 2016;14:20–32. doi: 10.1038/nrmicro3552.
- Hens B, Brouwers J, Corsetti M, Augustijns P. Supersaturation and Precipitation of Posaconazole Upon Entry in the Upper Small Intestine in Humans. J Pharm Sci. 2016;105:2677–2684. doi: 10.1002/jps.24690.
- Bailey CJ, Wilcock C, Scarpello JH. Metformin and the intestine. Diabetologia. 2008;51:1552–1553. doi: 10.1007/s00125-008-1053-5.
- Schloissnig S, et al. Genomic variation landscape of the human gut microbiome. Nature. 2013;493:45–50. doi: 10.1038/nature11711.
- Kuhn M, Letunic I, Jensen LJ, Bork P. The SIDER database of drugs and side effects. Nucleic acids research. 2016;44:D1075–1079. doi: 10.1093/nar/gkv1075.
- Bodet CA, 3rd, Jorgensen JH, Drutz DJ. Antibacterial activities of antineoplastic agents. Antimicrob Agents Chemother. 1985;28:437–439.
- Stringer AM, Gibson RJ, Bowen JM, Keefe DM. Chemotherapy-induced modifications to gastrointestinal microflora: evidence and implications of change. Curr Drug Metab. 2009;10:79–83.
- Sharma S, Singh A. Phenothiazines as anti-tubercular agents: mechanistic insights and clinical implications. Expert Opin Investig Drugs. 2011;20:1665–1676. doi: 10.1517/13543784.2011.628657.
- Morgan AP, et al. The antipsychotic olanzapine interacts with the gut microbiome to cause weight gain in mouse. PloS one. 2014;9:e115225. doi: 10.1371/journal.pone.0115225.
- Li XZ, Plesiat P, Nikaido H. The challenge of efflux-mediated antibiotic resistance in Gram-negative bacteria. Clin Microbiol Rev. 2015;28:337–418. doi: 10.1128/CMR.00117-14.
- Nagy E, Urban E, Nord CE, Bacteria, E. S. G. o. A. R. i. A Antimicrobial susceptibility of Bacteroides fragilis group isolates in Europe: 20 years of experience. Clin Microbiol Infect. 2011;17:371–379. doi: 10.1111/j.1469-0691.2010.03256.x.
- Cacace E, Kritikos G, Typas A. Chemical genetics in drug discovery. Current Opinion in Systems Biology. 2017;4:35–42. doi: 10.1016/j.coisb.2017.05.020.
- Morita Y, et al. NorM, a putative multidrug efflux protein, of Vibrio parahaemolyticus and its homolog in Escherichia coli. Antimicrob Agents Chemother. 1998;42:1778–1782.
- Sulavik MC, et al. Antibiotic susceptibility profiles of Escherichia coli strains lacking multidrug efflux pump genes. Antimicrob Agents Chemother. 2001;45:1126–1136. doi: 10.1128/AAC.45.4.1126-1136.2001.
- Nichols RJ, et al. Phenotypic Landscape of a Bacterial Cell. Cell. 2011;144:143–156.
- Nasie I, Steiner-Mordoch S, Schuldiner S. New substrates on the block: clinically relevant resistances for EmrE and homologues. J Bacteriol. 2012;194:6766–6770. doi: 10.1128/JB.01318-12.
- Ariza RR, Li Z, Ringstad N, Demple B. Activation of multiple antibiotic resistance and binding of stress-inducible promoters by Escherichia coli Rob protein. J Bacteriol. 1995;177:1655–1661.
- Gustafsson C, Persson BC. Identification of the rrmA gene encoding the 23S rRNA m1G745 methyltransferase in Escherichia coli and characterization of an m1G745-deficient mutant. J Bacteriol. 1998;180:359–365.
- Roldan MD, Perez-Reinado E, Castillo F, Moreno-Vivian C. Reduction of polynitroaromatic compounds: the bacterial nitroreductases. FEMS microbiology reviews. 2008;32:474–500. doi: 10.1111/j.1574-6976.2008.00107.x.
- Matthews DA, et al. Dihydrofolate reductase: x-ray structure of the binary complex with methotrexate. Science. 1977;197:452–455.
- Clemente JC, et al. The microbiome of uncontacted Amerindians. Sci Adv. 2015;1 doi: 10.1126/sciadv.1500183.
- Spanogiannopoulos P, Bess EN, Carmody RN, Turnbaugh PJ. The microbial pharmacists within us: a metagenomic view of xenobiotic metabolism. Nat Rev Microbiol. 2016;14:273–287. doi: 10.1038/nrmicro.2016.17.
see Supplementary Discussion.
- Kritikos G, et al. A tool named Iris for versatile high-throughput phenotyping in microorganisms. Nat Microbiol. 2017;2:17014. doi: 10.1038/nmicrobiol.2017.14.
- Rettedal EA, Gumpert H, Sommer MO. Cultivation-based multiplex phenotyping of human gut microbiota allows targeted recovery of previously uncultured bacteria. Nat Commun. 2014;5:4714. doi: 10.1038/ncomms5714.
- Goodman AL, et al. Extensive personal human gut microbiota culture collections characterized and manipulated in gnotobiotic mice. Proc Natl Acad Sci U S A. 2011;108:6252–6257. doi: 10.1073/pnas.1102938108.
- Qin J, et al. A human gut microbial gene catalogue established by metagenomic sequencing. Nature. 2010;464:59–65. doi: 10.1038/nature08821. nature08821 [pii]
- Qin J, et al. A metagenome-wide association study of gut microbiota in type 2 diabetes. Nature. 2012;490:55–60. doi: 10.1038/nature11450.
- Human Microbiome Project, C. Structure, function and diversity of the healthy human microbiome. Nature. 2012;486:207–214. doi: 10.1038/nature11234.
- Nielsen HB, et al. Identification and assembly of genomes and genetic elements in complex metagenomic samples without using reference genomes. Nat Biotechnol. 2014;32:822–828. doi: 10.1038/nbt.2939.
- Mende DR, Sunagawa S, Zeller G, Bork P. Accurate and universal delineation of prokaryotic species. Nature methods. 2013;10:881–884. doi: 10.1038/nmeth.2575.
- Kultima JR, et al. MOCAT2: a metagenomic assembly, annotation and profiling framework. Bioinformatics. 2016;32:2520–2523. doi: 10.1093/bioinformatics/btw183.
- Kruschke JK. Bayesian estimation supersedes the t test. J Exp Psychol Gen. 2013;142:573–603. doi: 10.1037/a0029146.
- Benjamini Y, Hochberg Y. Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing. Journal of the Royal Statistical Society. Series B (Methodological) 1995;57:289–300.
- Kuhn M, et al. STITCH 4: integration of protein-chemical interactions with user data. Nucleic acids research. 2014;42:D401–407. doi: 10.1093/nar/gkt1207.
- Deghou S, et al. CART-a chemical annotation retrieval toolkit. Bioinformatics. 2016;32:2869–2871. doi: 10.1093/bioinformatics/btw233.
- Mudie DM, et al. Quantification of gastrointestinal liquid volumes and distribution following a 240 mL dose of water in the fasted state. Mol Pharm. 2014;11:3039–3047. doi: 10.1021/mp500210c.
- Law V, et al. DrugBank 4.0: shedding new light on drug metabolism. Nucleic acids research. 2014;42:D1091–1097. doi: 10.1093/nar/gkt1068.
- Kim ER, Rhee PL. How to interpret a functional or motility test - colon transit study. J Neurogastroenterol Motil. 2012;18:94–99. doi: 10.5056/jnm.2012.18.1.94.
- Pritchard SE, et al. Fasting and postprandial volumes of the undisturbed colon: normal values and changes in diarrhea-predominant irritable bowel syndrome measured using serial MRI. Neurogastroenterol Motil. 2014;26:124–130. doi: 10.1111/nmo.12243.
- Turnidge J, Paterson DL. Setting and revising antibacterial susceptibility breakpoints. Clin Microbiol Rev. 2007;20:391–408. doi: 10.1128/CMR.00047-06. table of contents.
- Campillos M, Kuhn M, Gavin AC, Jensen LJ, Bork P. Drug target identification using side-effect similarity. Science. 2008;321:263–266. doi: 10.1126/science.1158140.
- Otsuka Y, et al. GenoBase: comprehensive resource database of Escherichia coli K-12. Nucleic acids research. 2015;43:D606–617. doi: 10.1093/nar/gku1164.
- Mori H, et al. Identification of essential genes and synthetic lethal gene combinations in Escherichia coli K-12. Methods Mol Biol. 2015;1279:45–65. doi: 10.1007/978-1-4939-2398-4_4.
- Wu H, et al. Metformin alters the gut microbiome of individuals with treatment-naive type 2 diabetes, contributing to the therapeutic effects of the drug. Nat Med. 2017;23:850–858. doi: 10.1038/nm.4345.
- Steinbeck C, et al. Recent developments of the chemistry development kit (CDK) - an open-source java library for chemo- and bioinformatics. Curr Pharm Des. 2006;12:2111–2120.
- Kim S, et al. PubChem Substance and Compound databases. Nucleic acids research. 2016;44:D1202–1213. doi: 10.1093/nar/gkv951.
Source: PubMed